Stroke Drug

The study found treatment with investigational drug, NXY059, resulted in a significant reduction in disability of stroke patients compared to treatment with a placebo.

This is the first positive study of a neuro-protectant, an emerging class of drugs currently being investigated as stroke treatments.

They may play a role in preventing or minimizing damage to brain tissue thereby reducing disability following an acute ischemic stroke.

Stroke is the number one cause of disability in the U.S. for adult Americans, affecting 700,000 Americans every year.

WTVY-TV 285 N Foster Street Dothan, AL 36303 334-792-3195
Copyright © 2002-2016 - Designed by Gray Digital Media - Powered by Clickability 2287751 -
Gray Television, Inc.